- Recent Funding
- Investors
- Lifeforce Capital
Lifeforce Capital portfolio
Lifeforce Capital has 5 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.
About this page
It is a venture capital firm based in Chevy Chase, US, founded in 2015. It led 1 of the 4 rounds it joined. Its most recent investment on record is Aspen Neuroscience's $115M Series B+ round in November 2025, alongside LYFE Capital, Kite Pharma, OrbiMed and 6 others. By category, its portfolio leans toward Health and bio (5) and Education (2). It has co-invested with S32, OrbiMed and LYFE Capital, most often S32 (3 rounds).
About Lifeforce Capital
What Lifeforce Capital invests in
- Health and bio · 5 · 100%
- Education · 2 · 40%
- Manufacturing and industrial · 1 · 20%
Lifeforce Capital recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series B+ · $115M | LYFE Capital, Kite Pharma, OrbiMed (lead) +6 | ||
| Series B+ · $147.5M | LYFE Capital (lead), Newton Investment Management, Mirae Asset Capital +6 | ||
| Series A · $18M | Casdin Capital, Cantos, Catalio +6 | ||
| Series A · $55M · lead | SV Angel, Refactor, Future Ventures +6 |
How Lifeforce Capital invests
Lifeforce Capital portfolio companies
AAspen Neuroscience$115MSeries B+ · Nov 2025
CCharacter Bio$18MSeries A · May 2022
664x Bio$55MSeries A · Jan 2022
EEnvedabacker
FFauna Biobacker
| Company | Round with Lifeforce Capital | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $115M | $339M | Nov 20, 2025 Series B+ |
Health and bio |
Series A · $18M | $111M | Mar 25, 2025 Series B+ |
Health and bio |
Series A · $55M · lead | $55M | Jan 19, 2022 Series A |
Health and bio |
backer | $714M | Sep 23, 2026 Series B+ |
Health and bio |
backer | $9M | Mar 14, 2025 Series A |
Most frequent co-investors
SS323 shared rounds · last Nov 20, 2025
OOrbiMed2 shared rounds · last Nov 20, 2025
LLYFE Capital2 shared rounds · last Nov 20, 2025
RRevelation Partners2 shared rounds · last Nov 20, 2025
MMedical Excellence Capital2 shared rounds · last Nov 20, 2025
FFrazier Life Sciences1 shared round · last Nov 20, 2025
CCormorant Asset Management1 shared round · last Nov 20, 2025
KKite Pharma1 shared round · last Nov 20, 2025
- PPrebys Ventures1 shared round · last Nov 20, 2025
GGV1 shared round · last May 18, 2022
MMirae Asset Capital1 shared round · last May 18, 2022
- NNewton Investment Management1 shared round · last May 18, 2022
Similar investors
BBdc Thrive venture5 companies · 3 deals in 12 mo
BBpifrance Digital Venture5 companies · 3 deals in 12 mo
CCatalyst Health Ventures5 companies · 3 deals in 12 mo
NNPIF – Mercia Equity Finance5 companies · 3 deals in 12 mo
VVirginia Innovation Partnership Corporation5 companies · 3 deals in 12 mo
AAdage Capital Management6 companies · 4 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Share is of the 4 rounds on Recent Funding that name Lifeforce Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Lifeforce Capital, which is a subset of its real portfolio. API: /api/v1/investors/lifeforce-capital (get a free API key). More: the most active VC firms and new venture capital funds.